All posts by imreal

Benefits of House Call Medicine Highlighted by COVID-19 Stay-At-Home Orders and Social Distancing, says Dr. Michael Farzam of House Call Doctor Los Angeles


Board-certified internist Dr. Michael Farzam.

Neglecting one’s ongoing health problems to avoid the risk of being exposed to viral illnesses can have some less than pleasant unexpected outcomes.

A May 31 article on Yahoo Finance reports on a prominent Los Angeles-based hospital’s recent efforts to encourage those in the community to prioritize their health and begin to start scheduling in-person visits when needed now that protocols have been set to make doctor visits safer. The article reports that many hospitals in Southern California never reached full capacity or experienced the surge in COVID-19 patients they expected. What the hospitals found, the article explains, was that the number of online-visits quickly rose from 150 a week to over 10,000 a week. The hospital community also found that the public was hesitant to step into hospitals or clinics, and many of those who have since returned to receive care for their non-coronavirus issues should have been seen much earlier. Dr. Michael Farzam of House Call Doctor Los Angeles says that, while social distancing remains extremely important, neglecting one’s ongoing health problems to avoid the risk of being exposed to viral illnesses can have some less than pleasant unexpected outcomes.

Dr. Michael Farzam says that house call medicine is a good alternative for individuals in need of general medical care but who are also looking to avoid medical buildings and clinics. Especially in the time of COVID, the board-certified physician says that the advantages of choosing house call doctors continue to increase. In addition to patients not needing to risk worsening their condition through the stress of going to a doctor’s office and sitting in a crowded waiting room full of other ill patients, they can rest comfortably at home without the risk of infecting others while medical care is brought directly to their doorsteps, says Dr. Michael Farzam.

While home visits from doctors might seem quaintly old-fashioned, Dr. Michael Farzam says the service has made a comeback due to advances in medical technology. Much like most other types of technology over the last two decades, medical equipment has miniaturized and become easily portable, allowing doctors to once again bring care directly to patients’ homes without sacrificing the best of 21st-century medical care, Dr. Michael Farzam explains.

There may be added benefits. Dr. Farzam says he can spend an average of 45 minutes with each patient, much longer than most clinic-based doctors are typically allowed. He also adds that, while virtual visits have their place, they also have obvious limitations. He recounts a case where a doctor visited an aging ill-patient with flu-like symptoms. Once the doctor arrived, the physicians immediately smelled the real problem — a gas leak that the elderly individual wasn’t able to smell. Sometimes, notes the doctor, there’s no substitute for showing up.

Readers interested in learning more about board-certified physician Dr. Michael Farzam and House Call Doctor Los Angeles can call (310) 849-7991 or visit https://www.housecalldoctorla.com.

Share article on social media or email:

World Allergy Week 2020 will address allergy care during the COVID-19 pandemic


World Allergy Week 2020 logo

Allergists can help ease patients’ concerns by identifying the differences between allergies and COVID-19, making health assessments, and reviewing treatment plans.

World Allergy Organization (WAO) will host World Allergy Week from June 28 to July 4, 2020, to emphasize the importance of maintaining regular care of allergies and asthma during the COVID-19 pandemic.

COVID-19, short for “coronavirus disease 2019”, is a disease spreading around the world caused by infection with a new strain of coronavirus (SARS-CoV-2). Patients with symptoms are very contagious, but even those with mild or no symptoms can still infect others. A vaccine against COVID-19 is not yet available.

A pandemic can be a time of anxiety for those with asthma and allergies such as allergic rhinitis (hay fever), eczema/dermatitis, allergic conjunctivitis, food allergies, and other conditions. Symptom similarity between allergies and COVID-19 can be confusing. Sneezing and itching, for example, are common in allergic rhinitis, while fever, fatigue, and shortness of breath appear in COVID-19. Allergists can help ease patients’ concerns by identifying the differences between allergies and COVID-19, making health assessments, and reviewing treatment plans.

“It is important that individuals do not stop taking their prescribed allergy or asthma medications, including inhaled or oral corticosteroids and other asthma controller medications – with or without a pandemic,” according to Sandra N. González-Díaz, MD, PhD, of Universidad Autónoma de Nuevo León in México. “They should consult their physicians about getting the care they need while limiting their exposure to the virus.” In many areas, health care practitioners use telemedicine and telephone consults for non-emergencies to avoid the risk of infection from face-to-face medical visits.

If you have asthma, continuing to control it could help you better defend against the virus. According to Bryan Martin, DO, of The Ohio State University in Columbus, Ohio, USA. “Most respiratory viruses are common triggers of severe asthma attacks. When you have asthma, underlying swelling and inflammation in the lungs can make it difficult to fight off viruses. Taking prescribed controller therapy daily, whether you have symptoms or not, helps repair that inflammation and fight off viruses more efficiently.”

Allergy care might change for patients infected with COVID-19, so it is important that they contact their physicians to discuss their symptoms as soon as possible. According to Motohiro Ebisawa, MD, PhD, of Sagamihara National Hospital in Sagamihara, Japan, and President of the World Allergy Organization. “Professional help is essential to understanding what is causing symptoms such as shortness of breath, chest tightness, or difficulty breathing. Patients should not assume these symptoms are either from their asthma or COVID-19 but consult their physicians immediately in case emergency care is needed.”

The international medical community agrees there is much to understand yet about COVID-19 and the best treatment for those who have become sick. World Allergy Week 2020 organizers are emphasizing the need for patients and physicians alike to stay updated on accurate medical information about COVID-19 and allergic disease and communicate regularly for optimal symptom management, disease prevention, and quality of life.

International allergy experts will present “COVID-19 and Allergic Diseases” a two hour-webinar with a live question and answer session, hosted by WAO on July 2, 2020. It will begin at 8:00 AM EDT (New York). Click here to find your local time: https://www.timeanddate.com/worldclock/converter-classic.html. Find details about the WAO webinar and registration and other resources at: http://www.worldallergyweek.org.

To find an allergy/immunology member society of the World Allergy Organization in your country or region, visit: http://www.worldallergy.org/about-wao/member-societies.

About the World Allergy Organization

The World Allergy Organization (WAO) is an international alliance of 103 regional and national allergy, asthma and immunology societies. Through collaboration with its Member Societies WAO provides a wide range of educational and outreach programs, symposia and lectureships to allergists/immunologists around the world and conducts initiatives related to clinical practice, service provision, and physical training in order to better understand and address the challenges facing allergists/immunologists worldwide. (http://www.worldallergy.org)

Share article on social media or email:

CSU Global president to lead educational innovation at Colorado State University System


CSU_System_logo

The CSU System is home to three universities: the flagship Colorado State University campus in Fort Collins, CSU Pueblo, and CSU Global.

Dr. Takeda-Tinker is an outstanding leader who has built a unique business model in higher education at CSU Global – and she’s ready to move forward and spearhead a new level of collaboration and partnership with industry, government, and within academia.

The Board of Governors of the Colorado State University System (csusystem.edu) today announced that Dr. Becky Takeda-Tinker, Colorado State University Global’s first president, will transition to a new role as chief educational innovation officer for the System.

CSU Global is unique as the first fully online, fully accredited public university in the country. Given this uniqueness and the desire to ensure continuity in leadership, the Board will conduct an internal search for the next president, with the goal of naming the new president at its August Board meeting.

“If the recent pandemic has taught us anything in higher education, it is that there are profound and untapped opportunities to deliver learning in new ways that provide a measurable return on investment for students and industries, particularly when it comes to workforce education,” CSU System Chancellor Tony Frank said. “Dr. Takeda-Tinker is an outstanding leader who has built a unique business model in higher education at CSU Global – and she’s ready to move forward and spearhead a new level of collaboration and partnership with industry, government, and within academia.”

The CSU System is home to three universities: the flagship Colorado State University campus in Fort Collins, CSU Pueblo, and CSU Global. The System also is building an educational complex, Spur, focused on food, water, and health at the National Western Center complex in Denver.

Takeda-Tinker joined CSU Global in 2008 as dean of academic affairs and a faculty member in organizational leadership and business management. She became president of the university in July 2010 and led it to become an industry leader in providing high-quality, workplace-relevant, online education.

“Becky has an exceptional track record as an innovator in education, along with more than two decades of leadership in business and management in the private sector,” Board Chair Nancy Tuor said. “We want to put that expertise to work for the citizens we serve in new ways that can return real value to Colorado. We are delighted she is willing to step into this new role, and confident we have a strong, capable leadership team at CSU Global who will keep the university moving forward and delivering great value to our students.”

The Evaluation Committee of the Board of Governors will function as the search committee for the new president. That committee includes all the voting members of the Board, and they will be joined by the student and faculty representatives to the Board from the Global campus. The search committee will solicit applications by July 3 in preparation for the announcement of a new president in August.

Takeda-Tinker, who holds a Ph.D. in organization and management and a master’s degree in finance, had a successful career in private industry and as a consultant on strategic and financial planning for corporations and nonprofits prior to joining CSU Global.

Highlights of Takeda-Tinker’s tenure at CSU Global include:

  • Growing CSU Global’s active student body to more than 20,000 in less than a decade.
  • Successfully completing and graduating more than 20,000 students through career-relevant bachelor’s and master’s programs, which have provided a measurable ROI for each of the university’s completed cohorts over the last 12 years.
  • Becoming the first 100% online state university in the U.S. with independent accreditation.
  • Helping the university pay back its origination loan ahead of schedule and making the university self-sustaining without the use of state funding, which it cannot receive by state statute.
  • Maintaining a highly affordable model for students. CSU Global operates only through student tuition and yet it has not raised tuition rates since 2011 and has never charged student fees.
  • Assisting with the passage of numerous legislative bills that allow CSU Global to serve all U.S. citizens with access to high-quality continued education programs, regardless of age or location.
  • Serving the U.S. Military, Colorado National Guard, as well as state and federal government employees with programs specifically designed for their unique career goals and needs.
  • Innovating online higher education by creating a highly accountable and adaptive organization that can address the specific needs of modern learners and businesses alike. This includes the creation and expansion of alternative credit options such as self-study and prior-learning assessments to allow students to customize their degree programs, partnering with over 3,000 corporate affiliates with tuition discounts and custom curricula to help upskill America’s workforce, and creating future-forward academic programs that are revised every year to ensure students are getting relevant and current industry knowledge and skills.
  • Leading a unique partnership with Aurora Public Schools that allows for lease payments of its headquarters to be used for scholarships, tuition discounts, and professional development of APS students, alumni, faculty, and staff.

“It has been an honor to serve as CSU Global’s president. I am deeply grateful to the many members of the CSU System Board of Governors who have served during my presidency, and to the State of Colorado’s leadership for their unceasing support of the impactful work CSU Global has been able to deliver over the years,” Takeda-Tinker said. “I am very excited to now be able to work more closely with Chancellor Tony Frank as the entire CSU System team prevails beyond one of the most challenging times in history.”

About Colorado State University System

Colorado State University System is comprised of three distinct universities: CSU, a leading public research university and the state’s only land-grant institution, located in Fort Collins; CSU Pueblo, a regional-serving campus and federally designated Hispanic-Serving Institution; and CSU Global, the nation’s first fully accredited online university. The CSU System’s institutions serve nearly 60,000 students annually. Learn more about the CSU System and its institutions, projects, and partnerships at csusystem.edu.

About Colorado State University Global

Colorado State University Global (CSU Global) offers career-relevant bachelor’s degrees, master’s degrees, and certificate programs for working adults and ontraditional learners. As the first and only 100% online, fully accredited, state university in the United States, CSU Global is focused on studentsuccess as its number one priority. Embracing the land-grant heritage as part of the Colorado State University System, CSU Global sets the standard for quality and innovation in higher education through its expert faculty, who are recognized as industry leaders and trained in working with adults in an online learning environment. CSU Global offers a streamlined enrollment process with accelerated eight-week courses that start every four weeks. Visit CSUGlobal.edu or call 1-800-920-6723 for more information.

Share article on social media or email:

Tinoco Joins LightWork® Software a Perryman Company


News Image

“LightWork® Software is at the forefront of enabling companies to unlock their full potential through proper employee utilization and development, Tinoco said. We offer companies and their owners profitable solutions to improve their bottom-line.”

LightWork® Software announces Donna Tinoco, APR has joined the team as head of its operations and business development. She brings to LightWork Software significant expertise in organizational development, branding, integrated marketing and public relations.

An award winning writer and strategist, she served as communication director as NASA’s Johnson Space Center’s Technology Transfer and Advanced Planning Offices, where she had the opportunity to work with leading technologists, inventors and scientists for innovation and business development initiatives. Since relocating to Florida, Tinoco has worked as a communications consultant and business development advisor to a number of Florida-based businesses including Space Coast start-ups, as well as a number of Florida destinations and attractions. She has assisted in raising capital, creating awareness and building business. She is an accredited in Public Relations (APR), and a member of the Public Relations Society of America (PRSA), and a former board member for the Florida Public Relations Society Volusia/Flagler Chapter. She also serves as an accreditation adjudicator for PRSA. Her career industry reach includes professional and legal services, manufacturing, medical and healthcare, higher education, real estate, finance, performing and fine arts, aerospace, technology and hospitality, travel and tourism.

“LightWork Software is an up and coming force in the human capital management (HCM) arena. LightWork Software’s suite of people, performance and learning management modules, coupled with its time and attendance, recruitment and analytics solutions provides companies and their human resources professionals the ability to make a difference in the growth and trajectory of their business,” said Tinoco.

LightWork Software is a Perryman Company, and was founded more than 20 years ago in DeLand, Florida. “LightWork is at the forefront of enabling companies to unlock their full potential through proper employee utilization and development, Tinoco said. We offer companies and their owners profitable solutions to improve their bottom line.”

LightWork Software HCM full suite includes, People Management, Time, Performance Management, Recruiting and Onboarding, Learning Management and Alerts and Workflow.

About LightWork Software

LightWork Software, a Perryman Company, empowers organizations and individuals to deliver more and be more. Headquartered in DeLand, Florida and serving clients since 1993 in the United States, Canada, and the Caribbean, LightWork Software’s focus is on people. Its human capital management (HCM) software solutions help companies grow and nurture employees. To learn more about LightWork Software visit: http://www.LightWorkSoftware.com.

Share article on social media or email:

Kenall Expands Virtually Impenetrable Correctional Luminaire Family with New Wall-Mount Fixtures


The dual-aperture, Mighty Mac WCBS has a bullnose profile and a doorless design for maximum safety.

The progress made in LED technology in recent years minimizes lighting maintenance and this, in turn, dramatically reduces inmate disruption, which protects everyone’s well-being.

Recently, Kenall Manufacturing introduced a series of four Mighty Mac® correctional luminaires that are virtually impenetrable, with no access points of any kind. Created specifically to keep staff and inmates safe, these luminaires are impervious to vandalism and contraband concealment. Now this series is expanding to include two new wall-mount luminaires; the dual-aperture Mighty Mac® WCBS and the single-aperture WCBHS.

While Kenall is known for extremely secure and durable correctional lighting solutions, but a customer request challenged engineers to create a luminaire with an enhanced level of protection for staff and inmates. The resulting fixture design eliminates the door, replacing it with a heavy-duty housing manufactured from a single piece of steel, preventing entry once the light fixture is installed. Long-life LEDs provide years of service-free illumination, and lenses are made of the toughest materials available and kept in place with a special bracket system fastened to the housing with through-studs. The entire fixture is secured to the wall or ceiling surface with 6 high-security bolts.

As with all Kenall Mighty Mac luminaires, personal safety is the number one priority for Kenall’s design team: “We were asked to create a unique luminaire that prevented access, unless completely removed,” said Tim Stevens, Kenall Product Manager. “The engineers really came through for the correctional community. The progress made in LED technology in recent years minimizes lighting maintenance and this, in turn, dramatically reduces inmate disruption, which protects everyone’s well-being,” Stevens concluded.

These unique Mighty Mac luminaires smaller housing is optimized for cells, making them less intrusive. The first of their kind, these new fixtures introduce an unprecedented level of security for both staff and inmates.

About Kenall

Kenall Manufacturing, an independent sector of Legrand, was founded in Chicago, Illinois in 1963 and has built a reputation for durable lighting solutions of superior quality and exceptional value. Today, the company creates unique solutions for the healthcare, cleanroom/containment, food processing, transportation, high abuse, and correctional lighting markets. Kenall luminaires are designed in Kenosha, Wisconsin, and comply with the Buy American Act (manufactured in the United States with more than 50% of the component cost of US origin). For additional information, visit http://www.kenall.com.

About Legrand and Legrand, North and Central America

Legrand is the global specialist in electrical and digital building infrastructures. Its comprehensive offering of solutions for use in commercial, industrial, and residential markets makes it a benchmark for customers worldwide. Legrand reported sales of approximately $7.1 billion (USD) in 2018. Legrand has a strong presence in North and Central America, with a portfolio of well-known market brands and product lines that includes AFCO Systems, C2G, Cablofil, Chief, Da-Lite, Electrorack, Finelite, Kenall, Luxul, Middle Atlantic Products, Milestone AV, Nuvo, OCL, On-Q, Ortronics, Pass & Seymour, Pinnacle, Projecta, QMotion, Quiktron, Raritan, Sanus, Server Technology, Solarfective, Vaddio, Vantage, Wattstopper, and Wiremold. Legrand is listed on Euronext Paris and is a component stock of indexes including the CAC40, http://www.legrand.us.

Share article on social media or email:

SupplyPro Announces the Put Your Money Where Your Mask Is Sales Promotion


SupplyPro Popular SupplyBay

“We are literally putting our money where customers need it most – PPE Vending,” said Stan Sigman, Chief Revenue Officer.

The Covid-19 pandemic has had an undeniable impact on the way we work. Worker safety is a top priority. Establishing a safe environment and compliant workforce is critical in in the post-Covid world.

To help our partners get back to work quickly and safely, SupplyPro is offering its popular SupplyBay vending machine below cost for a limited time only.

“We are literally putting our money where customers need it most – PPE Vending,” said Stan Sigman, Chief Revenue Officer. “We have gotten a lot of calls from customers who are looking to put everything from safety masks to latex gloves and sanitizer in the machines.” He went on to say, “Automated vending reduces human contact and every transaction is recorded – which increases accountability and benefits contact tracing.”

Taking action now, while the economy is still ramping back up, is the ideal time to position both industrial distributors and their customers for success – SAFELY. Essential safety supplies are dispensed to – the right people, at the right time, where it’s needed most. And compliance is documented to reduce risk and liability in this new environment.

SupplyPro is contributing to help get businesses back to work.

About SupplyPro – Headquartered in San Diego, California, SupplyPro is the leading provider of automated inventory management technologies, with a device-driven, cloud-based ecosystem that seamlessly meshes with most internal ERP systems and distributor delivery solutions. More than 1.8 million monthly users, from manufacturing to aerospace and high-tech fabrication, rely on the SupplyPro platform to increase efficiencies, profitability and competitiveness. For more information visit: http://supplypro.com/.

Share article on social media or email:

Charles E. Crutchfield III, MD and Crutchfield Dermatology Celebrates its 2,000th Virtual Telemedicine Visit


News Image

Charles E. Crutchfield III, M.D.

“If these first 2,000 encounters have taught us anything, it will be that our workflows may change, but more efficient care and widespread quality dermatologic care can be the result. That is our silver lining,” Dr.Crutchfield ended.

Charles E. Crutchfield III, M.D., a national leader in telemedicine and clinical dermatology, announced that he had personally conducted more than 2,000 virtual patient teledermatology visits and consultations last week at Crutchfield Dermatology. So far, telemedicine has proven to be a critical resource as the organization continues to serve patient needs despite ongoing disruptions caused by COVID-19. Dr. Crutchfield is still seeing patients in-office for acute cases that need personal attention. Many patients have opted for virtual telemedicine visits for initial screenings, follow-up appointments, and medicine refills. Additionally, Crutchfield Dermatology can service many small towns and rural areas in northern Minnesota that don’t have a dermatologist. “This is significantly raising the quality of dermatologic care for all of Minnesota citizens,” commented Darrin Rosha, a University of Minnesota Regent. We are also looking to participating in the Medical License Compact that allows a physician to be licensed and serve patients in 27 states. This ability to help patients in 27 states will be an incredible breakthrough, especially for states that don’t have access to a board-certified dermatologist.

“Crutchfield Dermatology is committed to providing high-quality skincare during this challenging time,” said Tim Quesnell, Clinic Manager at Crutchfield Dermatology. “We have created access to telemedicine across all of our offices so that patients can call their provider’s office and get an appointment, along with instructions on an easy-to-use platform for video conferencing. The most important thing we can do for our patients is to make sure they have access to care in the safest place for them, which, still, is their home right now.”

All a patient needs is a computer or smart device, an email address, and basic computer skills. Assistance and instructional help can be provided by the computer-savvy Crutchfield Dermatology staff, as needed. Crutchfield Dermatology supports Zoom, Skype, Google Duo, and several other live virtual platforms.

Charles E. Crutchfield III, M.D., Medical Director of Crutchfield Dermatology reports: “The accelerated development of this critical telemedicine offering is a testament to the nimble, multitalented staff here, and I couldn’t be prouder of the way we rose to the challenge and pushed to adapt for the benefit of our patients, our employees, and communities across the country.” He continued, “This unfortunate situation has brought the opportunity to recalibrate how we provide care. If these first 2,000 encounters have taught us anything, it will be that our workflows may change, but more efficient care and widespread quality dermatologic care can be the result. That is our silver lining,” Dr.Crutchfield ended.

About Charles E. Crutchfield III, M.D:

Charles E. Crutchfield III, M.D., is a graduate of the Mayo Clinic Medical School and a Clinical Professor of Dermatology at the University of Minnesota Medical School. He is currently the Medical Director of Crutchfield Dermatology in Eagan and is a Benedict Distinguished Professor of Biology at Carleton College. Dr. Crutchfield has won numerous teaching and professional awards and is the co-author of a children’s book on sun protection, a dermatology textbook, and hundreds of medial articles. He is a member of the AΩA National Medical Honor Society, an expert consultant for WebMD and CNN, and a recipient of the Karis Humanitarian Award from the Mayo Clinic School of Medicine. He is the team physician for the Minnesota Twins, Vikings, Wild, Timberwolves and Lynx professional sports teams. Dr. Crutchfield has over 25 years of clinical experience caring for patients.

Share article on social media or email:

Managing Partnerships Between Large and Small Organizations, Tailoring Your Alliance


Vantage Partners, a global consulting and training firm, announced that Vantage executives will lead three sessions at the June 23-25, virtual 2020 ASAP Global Alliance Summit. Vantage is a Platinum Sponsor of the event.

“Managing Power Imbalances: How to Navigate Partnerships between Large and Small Organizations,” is the topic of a livestreamed panel discussion moderated by Jessica Wadd, partner at Vantage Partners. Panelists will represent views from across both big and small companies across the Pharma and Technology industries.

“Partnerships between large organizations and smaller firms can generate massive value, but often bring unique management challenges,” according to Wadd. “Differently sized firms need to confront initial alliance misalignment across several key dimensions, including in perceived and real power, appetite for risk, execution speed, and autonomy. What’s the right alliance operating model to enable success? It looks good on paper, but will it hinder execution?”

“Alliance Management Skill-Building: Case Studies Across Industries,” is a session led by Wadd and Ben Siddall, partner at Vantage Partners.

“Unfortunately, many alliance management functions fail to implement a skill-building program that is right-sized and designed according to the specific needs, structure, and maturity of their partnering organization,” Siddall said.

Wadd and Siddall plan to draw real-world insights from multiple case studies of designing fit-for-purpose training programs to build alliance management competency in organizations from different industries and of different maturities. The session includes several interactive modules and activities, and tools to enable attendees to begin developing a plan for their own skill-building program.

“Big Pharma M&A and Alliance Portfolios: What’s at the End of the Rainbow?” is a panel moderated by Adam Kornetsky, engagement leader at Vantage Partners.

The past decade saw a frenzy of pharmaceutical deals, mergers, and acquisitions involving some of the biggest names in the industry. Kornetsky will lead a discussion among veteran alliance leaders about management of an alliance portfolio throughout an M&A process. Questions to be explored include: What are strategic considerations for acquirers—and the acquired? How is the value of the alliance portfolio characterized and communicated within large-scale M&As? How do you unlock and maximize this value?

Visit Vantage Partners’ 2020 Summit overview page to receive a 30% registration discount courtesy of Vantage. Learn more and register for the event at http://www.asapsummit.org.

ABOUT VANTAGE PARTNERS

Vantage Partners is a consulting and training firm that helps companies innovate more quickly, execute with greater discipline, and collaborate more effectively, for sustained impact and growth. Headquartered in Boston, Vantage serves clients worldwide, across multiple industries including biopharmaceuticals, healthcare, energy, financial services, technology, and manufacturing. The firm combines three decades of practical experience with an ongoing commitment to thought leadership. Vantage’s founders have served on the faculties of Harvard University, the Tuck School of Business at Dartmouth, and the U.S. Military Academy at West Point, and have published award-winning books and multiple articles in the Harvard Business Review and other leading journals. The Vantage Insights Center offers on-demand articles, research, case studies, white papers, and presentations. Learn more about the firm at http://www.vantagepartners.com.

Share article on social media or email:

Houston-Based imaware™ Collaborate with University Researchers to Understand Differences in Patient Vulnerabilities with COVID-19


imaware.health

imaware™, a Houston-based digital health platform organization, is collaborating with university researchers to understand differences in individual risk factors for COVID-19 and target them for early intervention and antiviral therapies. The initial priority of the research project is to understand why a portion of the patient population infected with COVID-19 are at a higher risk for becoming critically ill and how the virus spreads from infected individuals to members of their households.    

Sample collection is underway through the imaware™ healthcare professional-administered in-home testing process. All testing is conducted by a CLIA-certified laboratory using the CDC’s EUA-authorized test and protocol, and healthcare professionals are dispatched to patients’ homes to collect the samples for testing. During a sample collection, the same professional who performs the COVID-19 nasopharyngeal swab takes additional nasal swab samples, where investigators dive into understanding more about the spread of COVID-19 and the virus that causes it.

One aspect of the study is to understand host responses to virus complications caused by an overabundance of cytokines, which are proteins the body uses to fight viruses and infections. These cytokines, when functioning properly, rid the body of illness, but if not functioning properly, can trigger an over-exuberant inflammatory response leading to lung injury, organ failure and other severe complications with potentially deadly results.

Dr. Rebecca Fischer, an infectious disease expert and epidemiologist and laboratory scientist at the Texas A&M University School of Public Health, is also studying transmission in infected persons to others in their household. After a patient receives a positive diagnosis for COVID-19, her team contacts them to request permission to follow their journey, as well as track the spread of the virus within the household. Dr. Fischer gathers information from patients about the duration of their infections and their predispositions to reinfection. By identifying infected and uninfected individuals and collecting multiple samples at multiple time points in these individuals, critical information can be gleaned about the biology of the disease and its progression.

“As patient advocates, we want to aid in the search to understand more about why some patients are more vulnerable than others to the deadly complications of COVID-19. Our current sample collection process is an efficient way to provide longitudinal prospectively driven data for research and to our knowledge, is the only such approach that is collecting, assessing, and biobanking specimens in real time,” said imaware™ Cofounder Jani Tuomi.

Patient samples are stored at Texas A&M University and are invaluable to further study of the virus. At this time, they are interested in speaking with all infected individuals, but in the future, they may narrow the scope to a more targeted approach, as they adapt to what they learn through the research. These samples and data will be a rich resource for additional future studies to understand COVID-19 and SARS-Cov-2.

As part of the imaware™ testing process, the Wheel network contacts patients testing positive as well as provides telemedicine oversight and post-diagnosis care to CODID-19 patients.

“We believe strongly in supporting this research, as findings from the field can be implemented to improve clinical processes– helping even more patients,” said Wheel’s Executive Medical Director, Dr. Rafid Fadul.

# # #

About imaware™

imaware™ is a Houston, Texas based digital health platform organization, offering access to advanced and precise testing that empowers individuals with remote screening and monitoring of their health. imaware™ is uniquely positioned to serve in response to the COVID-19 pandemic by offering access to CDC’s EUA-authorized COVID-19 testing by partnering with a network of local and national healthcare organizations and a CLIA-certified laboratory.

Media Contacts:

Alicia Whitley – Account Supervisor

Lou Hammond Group, Houston

aliciaw@louhammond.com

281.794.4972

Jani Tuomi – Cofounder

imaware™

jani@imaware.health

1.855.502.9273

Share article on social media or email:

DuPont Washington Works Wins Prestigious American Chemistry Council Responsible Care® Award with Exceptional Merit


News Image

“We’re tremendously proud of this noted achievement.” said Greg Westbrook, Delrin unit manager, DuPont Washington Works

DuPont’s Washington Works production facility was recently awarded the prestigious Responsible Care® Energy Efficiency award from the American Chemistry Council (ACC). The Council presented 38 awards, 10 of which were acknowledged as projects of “Exceptional Merit.” DuPont received three awards with the Washington Works project distinguished among the recipients of an “Exceptional Merit” award.

“Operators, engineers, and leaders in our DuPont™ Delrin® production unit worked as a team to maximize our operating efficiency with changing market demand that resulted in a six percent improvement in energy efficiency,” said Greg Westbrook, Delrin unit manager, DuPont Washington Works. “This reduced our unit’s carbon footprint by 8,200 tons of CO2 in 2019 which is the equivalent of removing 1,800 cars from the road for one year. We’re tremendously proud of this noted achievement.”

Energy efficiency gains were achieved by:

  • Shifting load to achieve high-equipment efficiency
  • Adjusting utility supply (heating and cooling) to equipment demand
  • Scoping production and maintenance plans based on cost effectiveness

DuPont™ Delrin® is a tough, lightweight, and durable acetal polymer used in applications across multiple markets including transportation, materials handling, health care, and others.

The Responsible Care® Energy Efficiency Awards program is among ACC’s many initiatives to improve energy efficiency. Member companies are required to consider operational energy efficiency as well as waste minimization, reuse and recycling when developing environmental, health, safety, and security plans. ACC member companies nominate specific projects for recognition each year under the award program.

About DuPont Transportation & Industrial

DuPont Transportation & Industrial (T&I) delivers a broad range of technology-based products and solutions to the transportation, aerospace, electronics, healthcare, industrial and consumer markets. DuPont T&I partners with customers to drive innovation by utilizing its expertise and knowledge in polymer and materials science. DuPont T&I works with customers throughout the value chain to enable material systems solutions for demanding applications and environments. For additional information about DuPont Transportation & Industrial, visit the Home Page.

About DuPont

DuPont (NYSE: DD) is a global innovation leader with technology-based materials, ingredients and solutions that help transform industries and everyday life. Our employees apply diverse science and expertise to help customers advance their best ideas and deliver essential innovations in key markets electronics, transportation, construction, water, health and wellness, food and worker safety. More information can be found at http://www.dupont.com.

6/18/20

DuPont™, the DuPont Oval Logo, and all trademarks and service marks denoted with ™, ℠ or ® are owned by affiliates of DuPont de Nemours, Inc. unless otherwise noted. © 2019 DuPont.

For further information contact:

Christine Swart

248-979-4303

Christine.swart@dupont.com

Terri Howe, APR

616-997-6235

thowe@howemarketing.com

Share article on social media or email: